data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
Watch
YouTube
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Sonoma Pharmaceuticals
(NASDAQ:SNOA)
$3.01
-0.09[-2.90%]
At close: Aug 17
$2.99
-0.0200[-0.66%]
After Hours: 4:27PM EDT
Day High/Low2.95 - 3.08
52 Week High/Low2.55 - 4.85
Open / Close3.08 / 3.01
Float / Outstanding- / 3.1M
Vol / Avg.58.1K / 81.5K
Mkt Cap9.3M
P/E-
50d Avg. Price3.11
Div / Yield-
Payout Ratio-
EPS-0.29
Total Float3.1M

Sonoma Pharmaceuticals (NASDAQ:SNOA), Quotes and News Summary

Sonoma Pharmaceuticals (NASDAQ: SNOA)

Day High/Low2.95 - 3.08
52 Week High/Low2.55 - 4.85
Open / Close3.08 / 3.01
Float / Outstanding- / 3.1M
Vol / Avg.58.1K / 81.5K
Mkt Cap9.3M
P/E-
50d Avg. Price3.11
Div / Yield-
Payout Ratio-
EPS-0.29
Total Float3.1M
Sector: Health Care.Industry: Pharmaceuticals
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries.
Read More

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2022-11-14
REV
Q1 2023Est.ActualSurprise
EPS-0.290
REV3.983M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Sonoma Pharmaceuticals Questions & Answers

Q
How do I buy Sonoma Pharmaceuticals (SNOA) stock?
A

You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Sonoma Pharmaceuticals's (SNOA) competitors?
Q
What is the target price for Sonoma Pharmaceuticals (SNOA) stock?
A

The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Benchmark on Friday, July 20, 2018. The analyst firm set a price target for 3.00 expecting SNOA to fall to within 12 months (a possible -0.33% downside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Sonoma Pharmaceuticals (SNOA)?
A

The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $3.01 last updated August 17, 2022, 8:00 PM UTC.

Q
Does Sonoma Pharmaceuticals (SNOA) pay a dividend?
A

There are no upcoming dividends for Sonoma Pharmaceuticals.

Q
When is Sonoma Pharmaceuticals (NASDAQ:SNOA) reporting earnings?
A

Sonoma Pharmaceuticals’s Q2 earnings are confirmed for Monday, November 14, 2022.

Q
Is Sonoma Pharmaceuticals (SNOA) going to split?
A

There is no upcoming split for Sonoma Pharmaceuticals.

Q
What sector and industry does Sonoma Pharmaceuticals (SNOA) operate in?
A

Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.